A few days after a disappointing clinical trial readout for Syndax Pharma's Revuforj in one form of leukaemia, the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback